Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 111 P54 | DOI: 10.1530/endoabs.111.P54

BSPED2025 Poster Presentations Miscellaneous/Other 1 (9 abstracts)

To induce or not to induce – that is the question. delayed puberty in a male with anorexia and ARFID – a case report and literature review

Catriona McKay 1 , Noina Abid 1 , Linda Agnew 2 & Katherine Murtagh 1


1Royal Belfast Hospital for Sick Children, Belfast, United Kingdom; 2Belfast Health and Social Care Trust, Belfast, United Kingdom


A 14 year and 11 month old male, with anorexia nervosa, ARFID and a background of autism, rectal prolapse and bilateral scrotal fixation, presented to endocrine clinic with delayed puberty. His auxology, staging and bloods are shown (Table1&2). His investigations demonstrate he was clinically and biochemically pre-pubertal with delayed bone age. Due to an absence of evidence for pubertal induction with testosterone in anorexic males, priority focused on weight restoration. He was admitted for medical stabilisation prior to transfer to a mental health unit. He has spent over 6 months there and approaches weight restoration. There are no physical signs of puberty. It is hoped that if he maintains his weight these will ensue. This case is felt to be unusual - it is absence rather than arrest of puberty due to enduring anorexia and ARFID. ARFID is increasingly prevalent and is relevant to endocrinologists due to its effects on growth and puberty. Consideration was given to evidence for the use of testosterone in this cohort, which is limited, this has been identified as an area for further research.

Table 1 Auxology & pubertal staging
Date and location Age (Years and months) Height (Centimetres) Weight (Kilograms) BMI (kilograms per metres squared) Weight for Height (% of ideal BMI) Pubertal staging
First medical admission due to low weight 03/07/20 10y7m 144 26.8 12.9 76.3 Not done
Endocrine clinic 26/11/24 14y11m 147 27.3 12.6 65.3 G1P1A1 TV< 3mls
Medical admission 13/01/25 15y1m 147 26.7 12.4 64.2 G1P1A1 TV< 3mls
Discharge to IP MH facility 18/02/25 15y2m 147 29.8 13.8 71.5 G1P1A1 TV< 3mls
Latest measurements 07/07/25 15y7m 150 42.4 18.8 94.9 Staging pending Nil changes reported by patient/ staff
Table 2 Laboratory and imaging results
Date Test (units) Reference range Result
26/11/24 IGF-1 (nmol/l) 15.7 - 65.6 2.7
01/05/25 20.7
26/11/24 LH (IU/l) 1.7 - 8.6 <0.3
01/05/25 1.7
26/11/24 FSH (IU/l) 1.5 - 12.4 <0.3
01/05/25 3.6
26/11/24 Testosterone (nmol/l) Tanner stage 2 <15 0.4
01/05/25 <0.2
26/11/24 GH (ng/ml) N/a 3.2
26/11/24 Greulich & Pyle Bone Age Within two standard deviations of chronological age considered normal. 12.4years -2.22SD <mean for age

Volume 111

52nd Annual Meeting of the British Society for Paediatric Endocrinology and Diabetes

Sheffield, UK
12 Nov 2025 - 14 Nov 2025

British Society for Paediatric Endocrinology and Diabetes 

Browse other volumes

Article tools

My recent searches

No recent searches